Clinical Trials Browser

Has results × Sorafenib × Breast × Clear all

NCT00634634 2023-11-09

Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer

Phase 1/2 Completed

52 enrolled 14 charts

Breast Neoplasms

NCT00622466 2020-10-19

Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast Cancer

Phase 2 Terminated

20 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT02624700 2020-07-14

2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer

Phase 2 Terminated

13 enrolled 13 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01234337 2018-11-06

Phase III Trial Comparing Capecitabine in Combination With Sorafenib or Placebo in the Treatment of Locally Advanced or Metastatic HER2-Negative Breast Cancer

Phase 3 Completed

537 enrolled 24 charts

Breast Neoplasms

NCT00722072 2018-02-26

Sorafenib and Fulvestrant in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Aromatase Inhibitor Therapy

Phase 2 Terminated

12 enrolled 7 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00632541 2018-02-14

A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer

Phase 2 Terminated

18 enrolled 11 charts

Breast Neoplasms

NCT00828074 2017-02-27

Sorafenib and Vinorelbine in Treating Women With Stage IV Breast Cancer

Phase 1/2 Completed

46 enrolled 11 charts

Breast Neoplasms

NCT01194869 2016-10-18

Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer

Phase 2 Terminated

25 enrolled 8 charts

Breast Neoplasms

NCT00525161 2015-01-26

Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer

Phase 2 Terminated

11 enrolled 20 charts

Breast Neoplasms

NCT00825734 2014-12-22

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer

Phase 1/2 Completed

83 enrolled 8 charts

Breast Neoplasms

NCT00217399 2014-05-28

Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

Phase 1/2 Completed

35 enrolled 9 charts

Breast Neoplasms

NCT00493636 2014-05-20

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

Phase 2 Completed

160 enrolled 11 charts

Breast Neoplasms

NCT00101400 2013-12-13

BAY43-9006 - Phase II in Advanced Breast Cancer

Phase 2 Completed

54 enrolled 13 charts

Breast Neoplasms, Neoplasms

NCT00964743 2013-09-09

Depocyt® With Sorafenib in Neoplastic Meningitis

Phase NA Terminated

2 enrolled 6 charts

Breast Neoplasms, Neurologic Manifestations, Meningeal Carcinomatosis

NCT00544167 2013-04-01

Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer

Phase NA Completed

45 enrolled 5 charts

Breast Neoplasms